Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

At present, the various mechanisms involved in 5-fluorouracil (5-FU)-correlated cardiotoxicity remain to be elucidated and a universally accepted prophylaxis or treatment for this specific toxicity is not available. Although it may improve time to progression, survival and clinical benefit, a 5-FU-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cianci, G, Morelli, M F, Cannita, K, Morese, R, Ricevuto, E, Di Rocco, Z C, Porzio, G, Lanfiuti Baldi, P, Ficorella, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377120/
https://www.ncbi.nlm.nih.gov/pubmed/12771913
http://dx.doi.org/10.1038/sj.bjc.6600967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377120/
https://www.ncbi.nlm.nih.gov/pubmed/12771913
http://dx.doi.org/10.1038/sj.bjc.6600967

Ejemplares similares